The whole monkey case for klotho longevity shots rests on one study. A single low dose of klotho protein improved working memory in old rhesus monkeys (Study). They were about 22 years old on average, which is roughly 65 in human terms. No human trial has reported that klotho improves memory or extends life (Review). Clinics abroad already sell klotho gene therapy to healthy adults for tens of thousands of dollars (Report).
One animal study is a thin base for a $25,000 price tag.
What Klotho Actually Is
Klotho is a protein your body makes, mostly in the kidney. It is named after the Greek fate who spins the thread of life. Most of it stays fixed to the outside of cells. A piece can break off and travel in the blood, and that loose form is called soluble klotho.
Its day job is plumbing. Klotho helps the kidney handle phosphate, and it helps switch on vitamin D (Review). It also acts like a hormone. Its signals reach organs far from the kidney, including the brain (Review).
Blood levels tend to drop with age, though the link is loose (Study). In one set of reference values, adults aged 55 to 85 ran well below adults under 35 (Study). Levels also fall in long-term kidney disease (Review).
Low klotho is linked to a higher chance of dying from any cause (Review). That is a link, not a cause. Sick kidneys lower klotho, and sick kidneys shorten life on their own. So it is hard to say which one drives the other.
The same problem runs through the whole field. Almost everything we know about klotho in people comes from watching blood levels (Review). Nobody has changed those levels in a person and tracked what happened. The studies that did change klotho were done in animals.
The Mice That Started This
The name came from a mouse. In 1997 researchers broke the klotho gene in mice before birth. Those mice died young and could not breed. They also got hardened arteries, thin skin, weak bones and damaged lungs (Study). The paper said it looked like human aging.
The speed is the striking part. These mice grew normally for three or four weeks, then stopped growing and fell apart. They lived about two months, against two to three years for a normal lab mouse (Review).
Then came the opposite experiment. In 2005 a team bred mice that made extra klotho in every tissue from conception. They tested two lines of mice. Males lived about 20% longer than normal mice in one line, and about 31% longer in the other. Females gained about 19% (Study). Those are average lifespans. The biggest number came from one line in one sex.
The method matters here. Both experiments changed the gene in the embryo. Neither one gave klotho to a grown animal, and a shot sold to a 55-year-old is a different thing.
One Shot in Aged Monkeys
This is the study every seller points at. Researchers gave 18 old rhesus monkeys one injection of klotho protein under the skin (Study). The monkeys were 15 to 28 years old, about 22 on average, which is roughly 65 in human terms.
Then the animals did a memory task. They watch food get hidden in one of several wells, wait, then choose. The task tests working memory, the short-term space you use to hold a phone number in your head. Scores improved within four hours of the shot. On the harder version, the gain was still there about two weeks later (Study).
Two details usually get left out.
First, the team tested three doses, and only the smallest one worked. In a side part of the same study, only a handful of monkeys got each higher dose. Neither higher dose produced a clear change (Study). More was not better. The authors think a lower, more natural level may be the useful one.
Second, klotho does not seem to reach the brain. The same group injected klotho into the body and found none of it in brain tissue (Study). Something else seems to carry the message. Klotho stirs up platelets, the tiny cells that help blood clot. It raises blood levels of one substance they release, platelet factor 4. Injected on its own, that substance did reach the brain, and it improved memory in aging mice. In young mice, two common drugs that block platelets also blocked klotho’s memory benefit. That points to platelets as the go-between.
That may explain the odd timing. Klotho itself cleared out fast. The team estimated that half of it left the blood within about 30 hours (Study). That estimate rests on samples from just two monkeys. The memory gain lasted two full weeks.
Now the limits. Only about nine of the monkeys actually got the dose that worked. The team also declares its own business interests. They include a patent on klotho for thinking skills. Two of the authors founded a company to develop klotho treatments (Study). That is normal in this field, and worth knowing. One small monkey study is as far as this evidence goes.
Where Klotho Longevity Evidence Stops
There is human data. It comes from genetics, not from treatment.
Some people carry one copy of a klotho gene variant called KL-VS. In 2014 a study of 718 older adults without dementia found that carriers scored better on thinking tests (Study). About a quarter of that group were carriers. The result started much of the excitement, though the difference itself was small.
The same paper carries a warning. People with two copies got no benefit at all. The authors say a second copy wiped out the advantage, but they do not show that data. A gene that helps in one copy and not in two is not a simple lever.
Bigger groups then failed to find the benefit. A Danish study of 1,480 people aged 92 to 100 found no advantage (Study). Carriers scored slightly worse on a standard memory screen. A broader test pointed the same way, more weakly. Both gaps were small, and that group was decades older than the 2014 one.
A German study of 1,812 adults aged 55 to 87 found no benefit either (Study). Carriers scored slightly lower on every test it ran. Another team searched a huge UK health database of up to 335,074 people. It found too little evidence that klotho variants affect thinking or its decline (Preprint). That last one has not been checked by other scientists.
Even the 2014 finding would not justify a shot. Carrying a gene variant from birth is one thing. Topping up a protein in middle age is another. And no klotho therapy has been given to people for memory or lifespan (Review).
What the Clinics Actually Sell
The product is not a supplement. It is gene therapy. You get an injection of genetic instructions, so your own cells make more klotho.
Minicircle sells its follistatin gene therapy at a clinic in Roatan, Honduras, for a reported $25,000 a shot (Report). It is not approved in the United States. Reporting on the trade also names clinics in Mexico, Panama and the Bahamas. One of them, in Mexico, sells klotho gene therapy alongside it (Report).
Delivery differs by company. Minicircle uses a plasmid, a small ring of DNA, injected into belly fat (Registry). A competitor plans to deliver its follistatin product inside a modified virus (Report).
The only registered human klotho studies are run by the companies selling the therapy.
Two Minicircle pilots sit on the public registry. The first gave klotho gene therapy to 14 people (Registry). The second gave klotho plus follistatin to 14 more (Registry). Neither study had a comparison group, and everyone knew who got what. Neither had an outside committee watching the safety data.
Both records say the product is given outside the United States, beyond the reach of the FDA. The main things measured are your blood klotho level and side effects you report yourself. The combined pilot finished in April 2026 and still has no posted results.
A third study, from Klothea Bio, plans 21 people at the same clinic in Honduras. Two thirds would get klotho mRNA and one third a dummy injection, with nobody told which (Registry). That design is a real improvement. But the registry record, posted in April 2026, still reads “not yet recruiting”. The company had announced two months earlier that recruitment was under way (Announcement).
No klotho medicine is approved for sale anywhere. A 2024 review from the kidney field puts klotho replacement far from any clinical use (Review). Approval is not a quality badge. It is the process that produces the safety and benefit data nobody here has. The pattern will look familiar if you followed plasma exchange sold as a longevity treatment.
The Number They Sell You
A klotho blood test sounds like the responsible first step. It is not a number you can act on yet.
Labs measure soluble klotho in two main ways, and the two disagree. Researchers ran 112 blood samples through both, none of them ever frozen (Study). The results barely lined up. Among the 77 people in that trial who also had kidney function measured, the research method tracked kidney function closely. The commercial kit did not track it at all.
Reference ranges are shaky too. A widely used set comes from just 346 healthy adults, and its normal range runs from about 340 to 1,670 (Study). The top of normal is roughly five times the bottom. A larger group of 890 adults was measured with the same kit, and their middle values sat near 650 to 680 (Study). In that group, klotho tracked age and kidney function only weakly.
There is also no target. Nobody has shown that moving your klotho number changes your memory, your health or your lifespan. It is not even clear whether blood klotho reflects the klotho around your brain. For years the two were assumed to be separate. Newer reports suggest they may track each other, and nobody knows why the results clash (Review). A biological age test has the same problem: a precise-looking number with nothing proven attached to it.
Compare that with a kidney test. Kidney function has agreed ranges, a clear meaning and treatments that change what happens to you. That is what a number you can act on looks like.
What You Are Really Risking
Nobody has published safety data for klotho gene therapy in healthy people. The two finished pilots have posted nothing (Registry).
Some sellers deliver the gene inside a modified virus. That method has a known downside at high doses. In one study, 38 people got a virus-delivered gene therapy into the bloodstream (Study). Everyone on the standard steroid plan showed an immune reaction. Twenty of them had regular blood smears, and six of those developed signs of damage to small blood vessels. It showed up one to three weeks after the dose.
A group given two extra immune-calming drugs had almost none of that reaction. But nobody flipped a coin to decide who got what. The groups also differed in age, dose and product. All of it happened inside a supervised trial, with monitoring and a hospital able to respond. A clinic visit abroad comes with neither.
The wider record on medical tourism is not reassuring. One review of unproven cell treatments collected 35 published cases of serious harm or death, from clinics in 14 countries (Review). Reported harms included infections, tumors, heart events and vision loss. Most patients who took legal action ended up settling, with no court ruling. The authors treat 35 as an undercount, not a rate.
Aftercare is the other problem. Another review of this industry found that patients are rarely followed up once they leave (Review). It put the price of a single treatment at roughly $10,000 to $60,000 before travel. Those figures come from estimates published back in 2014. If a reaction starts three weeks later at home, your own doctor inherits a product they cannot look up.
None of this proves klotho gene therapy will hurt you. It means nobody can tell you the odds. And the people taking your money are the same people running the only studies.
Frequently Asked Questions
Is klotho longevity therapy available anywhere legally?
No klotho medicine has been approved for sale anywhere. A 2024 review from the kidney field puts klotho replacement far from any clinical use (Review). The clinics selling it work in places the approval system does not reach, such as Honduras, Panama and Mexico (Report). The registry records say the product is given beyond the reach of the FDA (Registry).
Can you buy klotho injections?
Yes, if you travel. A clinic in Mexico sells klotho gene therapy, and a related follistatin product costs a reported $25,000 a shot (Report). What you cannot buy is evidence that it works. No human trial has reported a benefit (Review).
Did klotho work in monkeys?
In one study, yes, in a narrow way. Old rhesus monkeys improved on a memory task within four hours of one low-dose injection. The gain was still there about two weeks later (Study). Only the smallest of three doses did anything, and about nine animals got it (Study).
Does exercise raise klotho?
It appears to. A pooled analysis of 12 reports covering 621 adults found blood klotho rose after at least 12 weeks of training (Meta-analysis). The studies disagreed with each other a lot, so the size of the rise is uncertain. Nobody has shown that exercise helps memory through klotho.
Is a klotho blood test worth paying for?
Probably not, outside research. The two main lab methods give different answers on the same blood (Study). Published ranges come from a few hundred people, and they are very wide (Study). There is no agreed target to aim at.
Key Takeaways
- It started with mouse genetics. Mice bred without working klotho aged fast and died at about two months (Study). Males bred to make extra klotho lived about 20% to 31% longer (Study).
- One monkey study, low dose only. One small injection improved memory in old monkeys within hours. The two higher doses did nothing clear (Study).
- Human genetics has not held up. The 2014 result in 718 adults (Study) did not repeat in 1,480 Danes (Study) or 1,812 Germans (Study).
- No human benefit data exists. The only registered klotho studies are run by the sellers. Each one enrolls about two dozen people, and none has posted results (Registry).
- The blood test is not a target. Two lab methods disagree on the same samples, and no number has been shown worth chasing (Study).
- Exercise is the one tested lever. Blood klotho rose after at least 12 weeks of training (Meta-analysis).
What Actually Raises Your Klotho
One thing on this whole list has been tested in people, and it is free.
Researchers pooled 12 reports covering 621 adults aged 30 to 65. Blood klotho rose after at least 12 weeks of training (Meta-analysis). A second pooled analysis looked at people with kidney disease. It covered four trials and 272 patients, with a coin flip deciding who trained, and klotho rose there too (Meta-analysis). Nearly all of that kidney evidence came from weight training, and four small trials is a thin base.
The researchers add a caveat of their own. None of those trials showed that the klotho rise caused anything good (Meta-analysis). Training already helps your heart, your muscles and your head for reasons we can measure directly. Treat the klotho number as a curiosity, not the point.
So the practical answer is a plain one. Train for twelve weeks because training works, not because it nudges a marker somebody wants to sell you.
Klotho is real biology, and one small monkey study gave a striking result. The evidence is worth watching. It has not arrived yet.
This article is for educational purposes and is not medical advice. Talk to a qualified clinician before changing your health regimen.
Leave a comment